Related Experiment Video
Updated: Jun 11, 2026
Mosaic Zebrafish Transgenesis for Functional Genomic Analysis of Candidate Cooperative Genes in Tumor Pathogenesis
Published on: March 31, 2015
Merlin expression in pediatric anaplastic ependymomas real time PCR study
Anna Maria Buccoliero1, Francesca Castiglione, Duccio Rossi Degl'Innocenti
1Department of Human Pathology and Oncology, University of Florence, Morgagni 85, Florence, Italy. ambuccoliero@unifi.it
Abstract:
The most common genetic abnormalities of ependymomas involve the chromosome 22 where there is the oncosuppressor gene neurofibromin 2 (NF2). NF2 mutations are primarily encountered in spinal lesions. In contrast, NF2 alterations do not seem related to tumor grade. We studied the NF2 expression through a real-time polymerase chain reaction in 25 pediatric anaplastic ependymomas. We compared the NF2 expression in neoplastic and non-neoplastic tissues, in supratentorial and infratentorial ependymomas and in primitive and non-primitive tumors (recurrences and metastases). Statistical analysis did not prove significant differences. Our results suggest that NF2 alterations are not typical of intracranial anaplastic ependymomas.
Insights
Genetic abnormalities in chromosome 22, specifically the neurofibromin 2 (NF2) gene, are common in ependymomas. However, NF2 alterations are not typical in pediatric intracranial anaplastic ependymomas.
Area of Science:
- Neuro-oncology
- Molecular genetics
- Cancer research
Background:
- Ependymomas are tumors arising from ependymal cells, often involving chromosome 22 and the neurofibromin 2 (NF2) tumor suppressor gene.
- NF2 mutations are frequently observed in spinal ependymomas but their role in intracranial tumors, particularly anaplastic types, remains less clear.
Observation:
- This study investigated NF2 gene expression in 25 pediatric anaplastic ependymomas using real-time polymerase chain reaction.
- Comparisons were made between neoplastic and non-neoplastic tissues, different tumor locations (supratentorial vs. infratentorial), and tumor types (primitive vs. recurrent/metastatic).
Findings:
- Statistical analysis revealed no significant differences in NF2 expression across the compared groups.
- These findings indicate that NF2 alterations are not a characteristic feature of pediatric intracranial anaplastic ependymomas.
Implications:
- The results suggest that NF2 status may not be a primary driver or reliable biomarker for intracranial anaplastic ependymomas.
- Further research into other genetic alterations is warranted to understand the pathogenesis of these specific brain tumors.
